-
Pharmacist-Led Education Improves Inhaler Satisfaction Adherence and Asthma Control in Asthma Patients
Sep 9, 2025, 16:22 PM -
Implications of Recent US Policy Changes on Evidence Generation Requirements for Enabling Access to Medicines and Vaccines in Low- and Middle-Income Countries
Sep 9, 2025, 16:22 PM -
Impact of Inclusion of Drug Adherence on Cost-Effectiveness of Inclisiran in Atherosclerotic Cardiovascular Disease (ASCVD) Patients
Sep 9, 2025, 16:22 PM -
Focus on Two Years of Economic Opinions on Solid Cancers (2023-2024): What Are the Specific Features vs. 2021-2022?
Sep 9, 2025, 16:22 PM -
Enterocutaneous Fistula (ECF) and Economic Burden Preliminary Data From a HEOR Model of a Laboratory (LAB) Experiment Plus Potential Cost Avoidance
Sep 9, 2025, 16:22 PM -
Societal Impact Analysis of Introducing Elexacaftor Tezacaftor Ivacaftor (ELX TEZ IVA) in the Management of People With Cystic Fibrosis in Germany: A Paid and Unpaid Work Productivity Approach
Sep 9, 2025, 16:22 PM -
Characteristics Associated With Having an Activity of Daily Living Limitation (ADLL) or Instrumental Activity of Daily Living Limitation (IADLL) Among US Adults With Asthma
Sep 9, 2025, 16:22 PM -
Cost Effectiveness and Budget Impact Analysis of Benralizumab for Treating Severe Uncontrolled Eosinophilic Asthma in Egypt
Sep 9, 2025, 16:22 PM -
Comparative Epidemiological Burden of Osteoarthritis in Eastern Central and Western Europe Based on the Global Burden of Disease Study 2021
Sep 9, 2025, 16:22 PM -
Developing a Multi-Indication Wider Societal Value Model to Estimate the Economic Impact of Semaglutide in Canada
Sep 9, 2025, 16:22 PM -
Review of Surrogate Endpoints’ Acceptance Trends in German HTA and Implications for EU Joint Clinical Assessment
Sep 9, 2025, 16:22 PM -
Informing the Sustainable Development of Novel Therapies Using Value-Based Real Options Analysis
Sep 9, 2025, 16:22 PM -
Standardizing Point-of-Care mRNA-Based Gene Therapy Production in Europe: A Cost and Capacity Analysis of the Nanospresso Platform
Sep 9, 2025, 16:22 PM -
NMAs of Systemic Therapies for Advanced Biliary Tract Cancer: A Systematic Review and Critical Appraisal Using RoB NMA
Sep 9, 2025, 16:22 PM -
Assessing the Environmental Value of Semaglutide: Reduction in GHG Emissions Resulting From the Treatment of Obese Individuals With Type 2 Diabetes
Sep 9, 2025, 16:22 PM -
Comparative Effectiveness of Second-Line Antidiabetic Medications on the Risk of Major Adverse Cardiovascular Events: A Real-World Study in China
Sep 9, 2025, 16:22 PM -
Evaluating the Efficacy of Artificial Intelligence Models as Suitable Screening Tools in Systematic Reviews: The Example of Glucagon-Like Peptide-1 Receptor Agonists in Heart Failure Treatment
Sep 9, 2025, 16:22 PM -
Evolving Trends in US Healthcare Policy: Perspectives From US Formulary Decision Makers
Sep 9, 2025, 16:22 PM -
A Model-Based Estimation of Productivity-Adjusted Life Years Due to Depression in Germany
Sep 9, 2025, 16:22 PM -
How Can Intravitreal Aflibercept 8 mg Impact Treatment Burden and Costs in European Patients With Diabetic Macular Edema? From Clinical Trials to Clinical Practice
Sep 9, 2025, 16:22 PM
